Acadia Pharmaceuticals

ACAD Mid Cap

Healthcare · Biotechnology

Aktualisiert: Apr 5, 2026, 17:43 UTC

$22.20

-0.54% heute

52W: $13.40 – $28.35

52W Low: $13.40 Position: 58.9% 52W High: $28.35

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

9.65x

Kurs/Gewinn-Verhältnis

Forward P/E

24.54x

Erwartetes KGV

P/S Ratio

3.53x

Kurs/Umsatz-Verhältnis

EV/EBITDA

25.89x

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$3.8B

Marktkapitalisierung

Umsatzwachstum

9.4%

YoY Umsatzwachstum

Gewinnmarge

36.49%

Nettomarge

ROE

39.89%

Eigenkapitalrendite

Beta

0.83

Marktsensitivität

Short Interest

7.88%

% der Aktien leerverkauft

Ø Volumen

1,679,719

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

Unterbewertet

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

Kaufen

20 Analysten

Ø Kursziel

$31.85

+43.47% Upside

Kursziel Spanne

$17.00 – $45.00

Über das Unternehmen

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a selective serotonin inverse agonist/antagonist for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 to treat the symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function. It also develops remlifanserin, which is in phase 2 clinical trial for the treatment of alzheimer's disease psychosis and lewy body dementia psychosis; ACP-211, which is in phase 2 clinical trial to treat major depressive disorder; A

Sektor: Healthcare Branche: Biotechnology Land: United States Mitarbeiter: 796 Börse: NMS

Trading-Daten

50-Day MA: $23.13

200-Day MA: $23.73

Volumen: 1,674,243

Ø Volumen: 1,679,719

Short Ratio: 4.85

Kurs/Buchwert: 3.08x

Verschuldung/EK: 4.25x

Free Cash Flow: $-54,821,124

Wo kann ich Acadia Pharmaceuticals kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →